搜索筛选:
搜索耗时3.4444秒,为你在为你在102,285,761篇论文里面共找到 2 篇相符的论文内容
发布年度:
A phase Ⅲ, open-label, randomized, multicenter study of eribulin mesylate versus capecitabine in pat
[会议论文] 作者：Awada,Christopher Twelves,Louise Yelle,Edith A.Perez,Jantien Wan d e rs,Martin S.Olivo,Yi He,Corina E.Dutcus,
来源：22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份：2013
...
A phase Ⅲ, open-label, randomized, multicenter study of eribulin mesylate versus capecitabine in pat
[会议论文] 作者：Awada,Christopher Twelves,Louise Yelle,Edith A.Perez,Jantien Wan d e rs,Martin S.Olivo,Yi He,Corina E.Dutcus,
来源：22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份：2013
Objective: Eribulin is a non-taxane microtubule dynamics inhibitor.In a previous phase Ⅲll trial, eribulin demonstrated a statistically significant improvement in overall survival (OS)versus current t...
相关搜索：
